WO2001055350A8 - Nucleic acids, proteins, and antibodies - Google Patents
Nucleic acids, proteins, and antibodiesInfo
- Publication number
- WO2001055350A8 WO2001055350A8 PCT/US2001/001350 US0101350W WO0155350A8 WO 2001055350 A8 WO2001055350 A8 WO 2001055350A8 US 0101350 W US0101350 W US 0101350W WO 0155350 A8 WO0155350 A8 WO 0155350A8
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- colorectal cancer
- polypeptides
- polynucleotides
- methods
- further relates
- Prior art date
Links
- 102000039446 nucleic acids Human genes 0.000 title abstract 2
- 108020004707 nucleic acids Proteins 0.000 title abstract 2
- 150000007523 nucleic acids Chemical class 0.000 title abstract 2
- 108091005461 Nucleic proteins Proteins 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 title 1
- 206010009944 Colon cancer Diseases 0.000 abstract 10
- 208000001333 Colorectal Neoplasms Diseases 0.000 abstract 10
- 229920001184 polypeptide Polymers 0.000 abstract 7
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 7
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 7
- 102000040430 polynucleotide Human genes 0.000 abstract 4
- 108091033319 polynucleotide Proteins 0.000 abstract 4
- 239000002157 polynucleotide Substances 0.000 abstract 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 3
- 239000000427 antigen Substances 0.000 abstract 2
- 102000036639 antigens Human genes 0.000 abstract 2
- 108091007433 antigens Proteins 0.000 abstract 2
- 210000001072 colon Anatomy 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 210000000664 rectum Anatomy 0.000 abstract 2
- 238000002560 therapeutic procedure Methods 0.000 abstract 2
- 206010027476 Metastases Diseases 0.000 abstract 1
- 239000000556 agonist Substances 0.000 abstract 1
- 239000005557 antagonist Substances 0.000 abstract 1
- 238000002405 diagnostic procedure Methods 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 238000010188 recombinant method Methods 0.000 abstract 1
- 238000012216 screening Methods 0.000 abstract 1
- 238000010189 synthetic method Methods 0.000 abstract 1
- 239000013598 vector Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6489—Metalloendopeptidases (3.4.24)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
The present invention relates to novel colorectal cancer related polynucleotides and the polypeptides encoded by these polynucleotides herein collectively known as 'colorectal cancer antigens', and the use of such colorectal cancer antigens for detecting disorders of the colon and/or rectum particularly the presence of colorectal cancer and colorectal cancer metastases. More specifically, isolated colorectal cancer associated nucleic acid molecules are provided encoding novel colorectal cancer associated polypeptides. Novel colorectal cancer polypeptides and antibodies that bind to these polypeptides are provided. Also provided are vectors, host cells, and recombinant and synthetic methods for producing human colorectal cancer associated polynucleotides and/or polypeptides. The invention further relates to diagnostic and therapeutic methods useful for diagnosing, treating, preventing and/or prognosing disorders related to the colon and/or rectum including colorectal cancer, and therapeutic methods for treating such disorders. The invention further relates to screening methods for identifying agonists and antagonists of polynucleotides and polypeptides of the invention. The present invention further relates to methods and/or compositions for inhibiting the production and function of the polypeptides of the present invention.
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU3972601A AU3972601A (en) | 2000-01-31 | 2001-01-08 | Nucleic acids, proteins, and antibodies |
| EP01914330A EP1252297A1 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
Applications Claiming Priority (235)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17906500P | 2000-01-31 | 2000-01-31 | |
| US60/179,065 | 2000-01-31 | ||
| US18062800P | 2000-02-04 | 2000-02-04 | |
| US60/180,628 | 2000-02-04 | ||
| US18466400P | 2000-02-24 | 2000-02-24 | |
| US60/184,664 | 2000-02-24 | ||
| US18635000P | 2000-03-02 | 2000-03-02 | |
| US60/186,350 | 2000-03-02 | ||
| US18987400P | 2000-03-16 | 2000-03-16 | |
| US60/189,874 | 2000-03-16 | ||
| US19007600P | 2000-03-17 | 2000-03-17 | |
| US60/190,076 | 2000-03-17 | ||
| US19812300P | 2000-04-18 | 2000-04-18 | |
| US60/198,123 | 2000-04-18 | ||
| US20551500P | 2000-05-19 | 2000-05-19 | |
| US60/205,515 | 2000-05-19 | ||
| US20946700P | 2000-06-07 | 2000-06-07 | |
| US60/209,467 | 2000-06-07 | ||
| US21488600P | 2000-06-28 | 2000-06-28 | |
| US60/214,886 | 2000-06-28 | ||
| US21513500P | 2000-06-30 | 2000-06-30 | |
| US60/215,135 | 2000-06-30 | ||
| US21688000P | 2000-07-07 | 2000-07-07 | |
| US21664700P | 2000-07-07 | 2000-07-07 | |
| US60/216,647 | 2000-07-07 | ||
| US60/216,880 | 2000-07-07 | ||
| US21748700P | 2000-07-11 | 2000-07-11 | |
| US21749600P | 2000-07-11 | 2000-07-11 | |
| US60/217,496 | 2000-07-11 | ||
| US60/217,487 | 2000-07-11 | ||
| US21829000P | 2000-07-14 | 2000-07-14 | |
| US60/218,290 | 2000-07-14 | ||
| US22096400P | 2000-07-26 | 2000-07-26 | |
| US22096300P | 2000-07-26 | 2000-07-26 | |
| US60/220,964 | 2000-07-26 | ||
| US60/220,963 | 2000-07-26 | ||
| US22575700P | 2000-08-14 | 2000-08-14 | |
| US22527000P | 2000-08-14 | 2000-08-14 | |
| US22521400P | 2000-08-14 | 2000-08-14 | |
| US22521300P | 2000-08-14 | 2000-08-14 | |
| US22451900P | 2000-08-14 | 2000-08-14 | |
| US22526700P | 2000-08-14 | 2000-08-14 | |
| US22526600P | 2000-08-14 | 2000-08-14 | |
| US22575800P | 2000-08-14 | 2000-08-14 | |
| US22544700P | 2000-08-14 | 2000-08-14 | |
| US22526800P | 2000-08-14 | 2000-08-14 | |
| US22575900P | 2000-08-14 | 2000-08-14 | |
| US22451800P | 2000-08-14 | 2000-08-14 | |
| US60/225,213 | 2000-08-14 | ||
| US60/225,214 | 2000-08-14 | ||
| US60/225,757 | 2000-08-14 | ||
| US60/225,267 | 2000-08-14 | ||
| US60/225,268 | 2000-08-14 | ||
| US60/224,519 | 2000-08-14 | ||
| US60/225,447 | 2000-08-14 | ||
| US60/225,266 | 2000-08-14 | ||
| US60/225,759 | 2000-08-14 | ||
| US60/224,518 | 2000-08-14 | ||
| US60/225,270 | 2000-08-14 | ||
| US60/225,758 | 2000-08-14 | ||
| US22627900P | 2000-08-18 | 2000-08-18 | |
| US60/226,279 | 2000-08-18 | ||
| US22668100P | 2000-08-22 | 2000-08-22 | |
| US22718200P | 2000-08-22 | 2000-08-22 | |
| US22686800P | 2000-08-22 | 2000-08-22 | |
| US60/227,182 | 2000-08-22 | ||
| US60/226,868 | 2000-08-22 | ||
| US60/226,681 | 2000-08-22 | ||
| US22700900P | 2000-08-23 | 2000-08-23 | |
| US60/227,009 | 2000-08-23 | ||
| US22892400P | 2000-08-30 | 2000-08-30 | |
| US60/228,924 | 2000-08-30 | ||
| US22934500P | 2000-09-01 | 2000-09-01 | |
| US22934400P | 2000-09-01 | 2000-09-01 | |
| US22928700P | 2000-09-01 | 2000-09-01 | |
| US22934300P | 2000-09-01 | 2000-09-01 | |
| US60/229,343 | 2000-09-01 | ||
| US60/229,287 | 2000-09-01 | ||
| US60/229,344 | 2000-09-01 | ||
| US60/229,345 | 2000-09-01 | ||
| US22951300P | 2000-09-05 | 2000-09-05 | |
| US22950900P | 2000-09-05 | 2000-09-05 | |
| US60/229,509 | 2000-09-05 | ||
| US60/229,513 | 2000-09-05 | ||
| US23043700P | 2000-09-06 | 2000-09-06 | |
| US23043800P | 2000-09-06 | 2000-09-06 | |
| US60/230,437 | 2000-09-06 | ||
| US60/230,438 | 2000-09-06 | ||
| US23141400P | 2000-09-08 | 2000-09-08 | |
| US23208100P | 2000-09-08 | 2000-09-08 | |
| US23141300P | 2000-09-08 | 2000-09-08 | |
| US23124200P | 2000-09-08 | 2000-09-08 | |
| US23208000P | 2000-09-08 | 2000-09-08 | |
| US23124300P | 2000-09-08 | 2000-09-08 | |
| US23124400P | 2000-09-08 | 2000-09-08 | |
| US60/231,242 | 2000-09-08 | ||
| US60/231,414 | 2000-09-08 | ||
| US60/231,243 | 2000-09-08 | ||
| US60/231,413 | 2000-09-08 | ||
| US60/231,244 | 2000-09-08 | ||
| US60/232,081 | 2000-09-08 | ||
| US60/232,080 | 2000-09-08 | ||
| US23196800P | 2000-09-12 | 2000-09-12 | |
| US60/231,968 | 2000-09-12 | ||
| US23306300P | 2000-09-14 | 2000-09-14 | |
| US23239800P | 2000-09-14 | 2000-09-14 | |
| US23306500P | 2000-09-14 | 2000-09-14 | |
| US23240000P | 2000-09-14 | 2000-09-14 | |
| US23239900P | 2000-09-14 | 2000-09-14 | |
| US23240100P | 2000-09-14 | 2000-09-14 | |
| US23306400P | 2000-09-14 | 2000-09-14 | |
| US23239700P | 2000-09-14 | 2000-09-14 | |
| US60/232,397 | 2000-09-14 | ||
| US60/232,398 | 2000-09-14 | ||
| US60/233,065 | 2000-09-14 | ||
| US60/233,064 | 2000-09-14 | ||
| US60/232,400 | 2000-09-14 | ||
| US60/233,063 | 2000-09-14 | ||
| US60/232,401 | 2000-09-14 | ||
| US60/232,399 | 2000-09-14 | ||
| US23422300P | 2000-09-21 | 2000-09-21 | |
| US23427400P | 2000-09-21 | 2000-09-21 | |
| US60/234,274 | 2000-09-21 | ||
| US60/234,223 | 2000-09-21 | ||
| US23499800P | 2000-09-25 | 2000-09-25 | |
| US23499700P | 2000-09-25 | 2000-09-25 | |
| US60/234,997 | 2000-09-25 | ||
| US60/234,998 | 2000-09-25 | ||
| US23548400P | 2000-09-26 | 2000-09-26 | |
| US60/235,484 | 2000-09-26 | ||
| US23583600P | 2000-09-27 | 2000-09-27 | |
| US23583400P | 2000-09-27 | 2000-09-27 | |
| US60/235,834 | 2000-09-27 | ||
| US60/235,836 | 2000-09-27 | ||
| US23636700P | 2000-09-29 | 2000-09-29 | |
| US23636800P | 2000-09-29 | 2000-09-29 | |
| US23632700P | 2000-09-29 | 2000-09-29 | |
| US23636900P | 2000-09-29 | 2000-09-29 | |
| US23637000P | 2000-09-29 | 2000-09-29 | |
| US60/236,367 | 2000-09-29 | ||
| US60/236,370 | 2000-09-29 | ||
| US60/236,327 | 2000-09-29 | ||
| US60/236,368 | 2000-09-29 | ||
| US60/236,369 | 2000-09-29 | ||
| US23704000P | 2000-10-02 | 2000-10-02 | |
| US23703900P | 2000-10-02 | 2000-10-02 | |
| US23703700P | 2000-10-02 | 2000-10-02 | |
| US23680200P | 2000-10-02 | 2000-10-02 | |
| US23703800P | 2000-10-02 | 2000-10-02 | |
| US60/237,037 | 2000-10-02 | ||
| US60/236,802 | 2000-10-02 | ||
| US60/237,039 | 2000-10-02 | ||
| US60/237,040 | 2000-10-02 | ||
| US60/237,038 | 2000-10-02 | ||
| US23993700P | 2000-10-13 | 2000-10-13 | |
| US23993500P | 2000-10-13 | 2000-10-13 | |
| US60/239,935 | 2000-10-13 | ||
| US60/239,937 | 2000-10-13 | ||
| US24182600P | 2000-10-20 | 2000-10-20 | |
| US24178600P | 2000-10-20 | 2000-10-20 | |
| US24178700P | 2000-10-20 | 2000-10-20 | |
| US24096000P | 2000-10-20 | 2000-10-20 | |
| US24180900P | 2000-10-20 | 2000-10-20 | |
| US24178500P | 2000-10-20 | 2000-10-20 | |
| US24180800P | 2000-10-20 | 2000-10-20 | |
| US24122100P | 2000-10-20 | 2000-10-20 | |
| US60/241,786 | 2000-10-20 | ||
| US60/241,809 | 2000-10-20 | ||
| US60/240,960 | 2000-10-20 | ||
| US60/241,826 | 2000-10-20 | ||
| US60/241,787 | 2000-10-20 | ||
| US60/241,221 | 2000-10-20 | ||
| US60/241,785 | 2000-10-20 | ||
| US60/241,808 | 2000-10-20 | ||
| US24461700P | 2000-11-01 | 2000-11-01 | |
| US60/244,617 | 2000-11-01 | ||
| US24647400P | 2000-11-08 | 2000-11-08 | |
| US24661000P | 2000-11-08 | 2000-11-08 | |
| US24661100P | 2000-11-08 | 2000-11-08 | |
| US24652800P | 2000-11-08 | 2000-11-08 | |
| US24647600P | 2000-11-08 | 2000-11-08 | |
| US24647700P | 2000-11-08 | 2000-11-08 | |
| US24647500P | 2000-11-08 | 2000-11-08 | |
| US24652500P | 2000-11-08 | 2000-11-08 | |
| US24652700P | 2000-11-08 | 2000-11-08 | |
| US24653200P | 2000-11-08 | 2000-11-08 | |
| US24652600P | 2000-11-08 | 2000-11-08 | |
| US60/246,476 | 2000-11-08 | ||
| US60/246,528 | 2000-11-08 | ||
| US60/246,475 | 2000-11-08 | ||
| US60/246,525 | 2000-11-08 | ||
| US60/246,524 | 2000-11-08 | ||
| US60/246,477 | 2000-11-08 | ||
| US60/246,611 | 2000-11-08 | ||
| US60/246,610 | 2000-11-08 | ||
| US60/246,609 | 2000-11-08 | ||
| US60/246,478 | 2000-11-08 | ||
| US60/246,527 | 2000-11-08 | ||
| US60/246,474 | 2000-11-08 | ||
| US60/246,532 | 2000-11-08 | ||
| US60/246,526 | 2000-11-08 | ||
| US60/246,523 | 2000-11-08 | ||
| US60/246,613 | 2000-11-08 | ||
| US60/249,264 | 2000-11-17 | ||
| US60/249,211 | 2000-11-17 | ||
| US60/249,245 | 2000-11-17 | ||
| US60/249,213 | 2000-11-17 | ||
| US60/249,216 | 2000-11-17 | ||
| US60/249,215 | 2000-11-17 | ||
| US60/249,300 | 2000-11-17 | ||
| US60/249,209 | 2000-11-17 | ||
| US60/249,207 | 2000-11-17 | ||
| US60/249,208 | 2000-11-17 | ||
| US60/249,265 | 2000-11-17 | ||
| US60/249,210 | 2000-11-17 | ||
| US60/249,244 | 2000-11-17 | ||
| US60/249,214 | 2000-11-17 | ||
| US60/249,299 | 2000-11-17 | ||
| US60/249,218 | 2000-11-17 | ||
| US60/249,217 | 2000-11-17 | ||
| US60/249,297 | 2000-11-17 | ||
| US60/249,212 | 2000-11-17 | ||
| US60/250,391 | 2000-12-01 | ||
| US60/250,160 | 2000-12-01 | ||
| US60/251,988 | 2000-12-05 | ||
| US60/251,030 | 2000-12-05 | ||
| US60/256,719 | 2000-12-05 | ||
| US60/251,479 | 2000-12-06 | ||
| US60/251,869 | 2000-12-08 | ||
| US60/251,868 | 2000-12-08 | ||
| US60/251,989 | 2000-12-08 | ||
| US60/251,856 | 2000-12-08 | ||
| US60/251,990 | 2000-12-08 | ||
| US60/254,097 | 2000-12-11 | ||
| US60/259,678 | 2001-01-05 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO2001055350A1 WO2001055350A1 (en) | 2001-08-02 |
| WO2001055350A8 true WO2001055350A8 (en) | 2001-09-07 |
Family
ID=27587117
Family Applications (48)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/US2001/001356 WO2001055173A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001342 WO2001059064A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001315 WO2001055311A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001311 WO2001055309A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001337 WO2001055205A1 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001310 WO2001055387A1 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001317 WO2001055201A1 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001325 WO2001055202A1 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001338 WO2001055367A1 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001354 WO2001057182A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001240 WO2001055302A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001348 WO2001055368A1 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001358 WO2001055163A1 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001309 WO2001055308A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001312 WO2001054733A1 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins and antibodies |
| PCT/US2001/001301 WO2001055303A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001353 WO2001055206A1 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001340 WO2001055321A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001359 WO2001055328A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001314 WO2001055310A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001324 WO2001055314A2 (en) | 2000-01-31 | 2001-01-17 | Digestive system related nucleic acids, proteins and antibodies |
| PCT/US2001/001351 WO2001055355A1 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001322 WO2001055343A1 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001326 WO2001055315A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001344 WO2001055324A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001333 WO2001055448A1 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001332 WO2001055318A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001343 WO2001055323A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001306 WO2001055307A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001349 WO2001054474A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001302 WO2001055304A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001336 WO2001055204A1 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001327 WO2001055203A1 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001313 WO2001055200A1 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001316 WO2001054473A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001352 WO2001055327A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001345 WO2001055325A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001350 WO2001055350A1 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001321 WO2001055312A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001341 WO2001055322A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001357 WO2001055208A1 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001328 WO2001055316A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001239 WO2001055301A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001330 WO2001055447A1 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001308 WO2001055364A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001335 WO2001055319A2 (en) | 2000-01-31 | 2001-01-17 | Endocrine related nucleic acids, proteins and antibodies |
| PCT/US2001/001339 WO2001055320A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001355 WO2001055207A1 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
Family Applications Before (37)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/US2001/001356 WO2001055173A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001342 WO2001059064A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001315 WO2001055311A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001311 WO2001055309A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001337 WO2001055205A1 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001310 WO2001055387A1 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001317 WO2001055201A1 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001325 WO2001055202A1 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001338 WO2001055367A1 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001354 WO2001057182A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001240 WO2001055302A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001348 WO2001055368A1 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001358 WO2001055163A1 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001309 WO2001055308A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001312 WO2001054733A1 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins and antibodies |
| PCT/US2001/001301 WO2001055303A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001353 WO2001055206A1 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001340 WO2001055321A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001359 WO2001055328A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001314 WO2001055310A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001324 WO2001055314A2 (en) | 2000-01-31 | 2001-01-17 | Digestive system related nucleic acids, proteins and antibodies |
| PCT/US2001/001351 WO2001055355A1 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001322 WO2001055343A1 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001326 WO2001055315A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001344 WO2001055324A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001333 WO2001055448A1 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001332 WO2001055318A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001343 WO2001055323A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001306 WO2001055307A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001349 WO2001054474A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001302 WO2001055304A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001336 WO2001055204A1 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001327 WO2001055203A1 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001313 WO2001055200A1 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001316 WO2001054473A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001352 WO2001055327A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001345 WO2001055325A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
Family Applications After (10)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/US2001/001321 WO2001055312A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001341 WO2001055322A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001357 WO2001055208A1 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001328 WO2001055316A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001239 WO2001055301A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001330 WO2001055447A1 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001308 WO2001055364A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001335 WO2001055319A2 (en) | 2000-01-31 | 2001-01-17 | Endocrine related nucleic acids, proteins and antibodies |
| PCT/US2001/001339 WO2001055320A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
| PCT/US2001/001355 WO2001055207A1 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
Country Status (3)
| Country | Link |
|---|---|
| AU (16) | AU2001241415A1 (en) |
| CA (37) | CA2395827A1 (en) |
| WO (48) | WO2001055173A2 (en) |
Families Citing this family (273)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001070982A2 (en) * | 2000-03-23 | 2001-09-27 | Immusol Incorporated | Brca-1 regulators and methods of use |
| WO2002008288A2 (en) * | 2000-07-20 | 2002-01-31 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| WO1999060127A2 (en) | 1998-05-15 | 1999-11-25 | Genentech, Inc. | Il-17 homologous polypeptides and therapeutic uses thereof |
| US20020137890A1 (en) | 1997-03-31 | 2002-09-26 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| US6706262B1 (en) | 1998-03-18 | 2004-03-16 | Corixa Corporation | Compounds and methods for therapy and diagnosis of lung cancer |
| US7258860B2 (en) | 1998-03-18 | 2007-08-21 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of lung cancer |
| US7579160B2 (en) | 1998-03-18 | 2009-08-25 | Corixa Corporation | Methods for the detection of cervical cancer |
| US6960570B2 (en) | 1998-03-18 | 2005-11-01 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of lung cancer |
| US7771719B1 (en) | 2000-01-11 | 2010-08-10 | Genentech, Inc. | Pharmaceutical compositions, kits, and therapeutic uses of antagonist antibodies to IL-17E |
| US6929938B2 (en) | 2001-08-15 | 2005-08-16 | Millennium Pharmaceuticals, Inc. | 25501, a human transferase family member and uses therefor |
| US7141417B1 (en) | 1999-02-25 | 2006-11-28 | Thomas Jefferson University | Compositions, kits, and methods relating to the human FEZ1 gene, a novel tumor suppressor gene |
| EP1163252A4 (en) * | 1999-02-25 | 2004-04-07 | Univ Jefferson | Compositions, kits, and methods relating to the human fez1 gene, a novel tumor suppressor gene |
| WO2000050458A1 (en) * | 1999-02-26 | 2000-08-31 | Smithkline Beecham Corporation | Cloning of a p2y-like 7tm receptor (axor17) |
| JP2004506402A (en) * | 1999-03-23 | 2004-03-04 | ヒューマン ジノーム サイエンシーズ， インコーポレイテッド | 48 human secretory proteins |
| WO2000058480A1 (en) | 1999-03-29 | 2000-10-05 | Kansai Technology Licensing Organization Co., Ltd. | Novel cytidine deaminase |
| EP1637541B1 (en) * | 1999-09-01 | 2010-03-03 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| AU1238201A (en) * | 1999-10-27 | 2001-05-08 | Millennium Pharmaceuticals, Inc. | Novel molecules and the card-related protein family and uses thereof |
| US6893818B1 (en) | 1999-10-28 | 2005-05-17 | Agensys, Inc. | Gene upregulated in cancers of the prostate |
| US7005499B1 (en) * | 1999-11-18 | 2006-02-28 | Genentech, Inc. | Wnt-regulated cytokine-like polypeptide and nucleic acids encoding same |
| EP1878794A3 (en) * | 1999-11-30 | 2008-01-23 | Genentech, Inc. | Compositions and methods for the treatment of immune related diseases |
| CA2491610A1 (en) * | 1999-12-01 | 2001-06-07 | Kevin P. Baker | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| CN1300781A (en) * | 1999-12-22 | 2001-06-27 | 上海博德基因开发有限公司 | Polypeptide-human SHC protein 43 and polynucleotide for coding this polypeptide |
| US20040043397A1 (en) | 2000-01-11 | 2004-03-04 | Genentech, Inc. | IL-17 homologous polypeptides and therapeutic uses thereof |
| WO2001055391A2 (en) | 2000-01-26 | 2001-08-02 | Agensys, Inc | 84p2a9: a prostate and testis specific protein highly expressed in prostate cancer |
| US6953682B2 (en) | 2000-02-10 | 2005-10-11 | Millennium Pharmaceuticals, Inc. | Nucleic acid sequences encoding adenylate kinase, phospholipid scramblase-like, DNA fragmentation factor-like, phosphatidylserine synthase-like, and atpase-like molecules and uses therefor |
| US20020082212A1 (en) * | 2000-07-20 | 2002-06-27 | Millennium Pharmaceuticals, Inc. | 7716, a novel human ATPase and uses therefor |
| US7078205B2 (en) | 2000-02-17 | 2006-07-18 | Millennium Pharmaceuticals, Inc. | Nucleic acid sequences encoding melanoma associated antigen molecules, aminotransferase molecules, atpase molecules, acyltransferase molecules, pyridoxal-phosphate dependent enzyme molecules and uses therefor |
| US20020031815A1 (en) * | 2000-06-26 | 2002-03-14 | Millennium Pharmaceuticals, Inc. | 46619, a novel human beta-ketoacyl synthase and uses thereof |
| US20020055159A1 (en) * | 2000-06-15 | 2002-05-09 | Meyers Rachel A. | 23680,a novel human aminotransferase and uses therefor |
| US7718397B2 (en) | 2000-03-21 | 2010-05-18 | Genentech, Inc. | Nucleic acids encoding receptor for IL-17 homologous polypeptides and uses thereof |
| US20020025931A1 (en) | 2000-03-24 | 2002-02-28 | Rachel Meyers | 3714, 16742, 23546, and 13887 novel protein kinase molecules and uses therefor |
| US20030198953A1 (en) * | 2000-03-30 | 2003-10-23 | Spytek Kimberly A. | Novel proteins and nucleic acids encoding same |
| US7632929B2 (en) | 2000-04-20 | 2009-12-15 | The Board Of Trustees Of The University Of Arkansas | Methamphetamine-like hapten compounds, linkers, carriers and compositions and uses thereof |
| CA2407044A1 (en) | 2000-04-25 | 2001-11-01 | Lexicon Genetics Incorporated | Novel human kinase proteins and polynucleotides encoding the same |
| AU2001257407A1 (en) * | 2000-04-26 | 2001-11-07 | Millennium Pharmaceuticals, Inc. | 21657, a human short-chain dehydrogenase and uses thereof |
| US6808876B1 (en) | 2000-05-02 | 2004-10-26 | Immusol, Inc. | Cellular regulators of infectious agents and methods of use |
| EP1278863A2 (en) * | 2000-05-12 | 2003-01-29 | MERCK PATENT GmbH | Human serine-threonine kinase-4 |
| US20040175815A1 (en) * | 2000-05-26 | 2004-09-09 | Yonghong Xiao | Regulation of human p78-like serube/threonine kinase |
| EP1158001B1 (en) * | 2000-05-26 | 2007-11-14 | F. Hoffmann-La Roche Ag | A nucleic acid which is upregulated in human tumor cells, a protein encoded thereby and a process for tumor diagnosis |
| DE10027170A1 (en) * | 2000-05-31 | 2001-12-13 | Schering Ag | Human PEM as a target for fertility control |
| AU6531101A (en) * | 2000-06-02 | 2001-12-17 | Genentech Inc | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| WO2001093805A2 (en) * | 2000-06-02 | 2001-12-13 | The Brigham & Women's Hospital, Inc. | FUSION OF jAZF1 AND jjAZ1 GENES IN ENDOMETIRIAL STROMAL TUMORS |
| US20030096969A1 (en) | 2000-06-02 | 2003-05-22 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| WO2001094385A2 (en) * | 2000-06-05 | 2001-12-13 | Bayer Aktiengesellschaft | Human hm74-like g protein coupled receptor |
| US6323016B1 (en) | 2000-06-09 | 2001-11-27 | Pe Corporation (Ny) | Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| EP1287029A2 (en) * | 2000-06-09 | 2003-03-05 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of colon cancer |
| CA2409315A1 (en) * | 2000-06-16 | 2001-12-20 | Incyte Genomics, Inc. | Protein phosphatases |
| EP2075253A1 (en) * | 2000-06-23 | 2009-07-01 | Genentech, Inc. | Compositions and methds for the diagnosis and treatment of disorders involving angiogensis |
| EP1309684A2 (en) * | 2000-06-27 | 2003-05-14 | Curagen Corporation | Polynucleotides and polypeptides encoded thereby |
| US7094587B2 (en) | 2000-06-27 | 2006-08-22 | Millennium Pharmaceuticals, Inc. | 16002 Molecules and uses therefor |
| AU2001271621A1 (en) | 2000-06-28 | 2002-01-08 | Diadexus, Inc. | Method of diagnosing, monitoring, staging, imaging and treating colon cancer |
| US6900303B2 (en) | 2000-06-30 | 2005-05-31 | Millennium Pharmaceuticals, Inc. | 57658, a novel human uridine kinase and uses thereof |
| WO2002004510A2 (en) * | 2000-07-07 | 2002-01-17 | Incyte Genomics, Inc. | Gtp-binding proteins |
| WO2002004520A2 (en) * | 2000-07-07 | 2002-01-17 | Incyte Genomics, Inc. | Transporters and ion channels |
| WO2002006326A2 (en) * | 2000-07-14 | 2002-01-24 | Millennium Pharmaceuticals, Inc. | 62088, a human nucleoside phosphatase family member and uses thereof |
| AU2001281967A1 (en) * | 2000-07-18 | 2002-01-30 | Bayer Aktiengesellschaft | Regulation of human desc1-like serine protease |
| WO2002006318A2 (en) * | 2000-07-18 | 2002-01-24 | Board Of Regents, The University Of Texas System | Methods and compositions for stabilizing microtubules and intermediate filaments in striated muscle cells |
| CA2418198A1 (en) * | 2000-07-25 | 2002-01-31 | Merck Patent Gesellschaft Mit Beschraenkter Haftung | Novel protein containing ring finger domaine r1p4 |
| WO2002008281A2 (en) * | 2000-07-26 | 2002-01-31 | Stanford University | Bstp-cad protein and related reagents and methods of use thereof |
| WO2002008282A2 (en) * | 2000-07-26 | 2002-01-31 | Stanford University | Bstp-ras/rerg protein and related reagents and methods of use thereof |
| EP1657254A3 (en) * | 2000-08-01 | 2006-06-07 | Genentech, Inc. | Polypeptide, nucleic acid encoding it, and their use for the diagnosis of cancer |
| US7335732B2 (en) | 2000-08-01 | 2008-02-26 | Genentech, Inc. | PRO9799 polypeptides |
| EP1307557A2 (en) | 2000-08-02 | 2003-05-07 | The Johns Hopkins University | Endothelial cell expression patterns |
| EP1315431A1 (en) * | 2000-08-02 | 2003-06-04 | Millennium Pharmaceuticals, Inc. | A human gtp-releasing factor family member (15368) and uses therefor |
| WO2002012330A2 (en) * | 2000-08-04 | 2002-02-14 | Zymogenetics, Inc. | Human secreted protein, zzp1 |
| WO2002012285A2 (en) * | 2000-08-10 | 2002-02-14 | Board Of Regents, The University Of Texas System | The tumor suppressor car-1 |
| WO2002014355A2 (en) * | 2000-08-11 | 2002-02-21 | Merck Patent Gmbh | Novel mitogen activated kinase |
| EP1326985A1 (en) * | 2000-08-18 | 2003-07-16 | MERCK PATENT GmbH | Identification of a human n-terminal acetyltransferase gene |
| WO2002016586A2 (en) * | 2000-08-21 | 2002-02-28 | Bristol-Myers Squibb Company | Adenosine deaminase homolog |
| JP2004519217A (en) * | 2000-08-21 | 2004-07-02 | インサイト・ゲノミックス・インコーポレイテッド | Microtubule-associated proteins and tubulin |
| AU2001284655A1 (en) * | 2000-08-24 | 2002-03-04 | Eli Lilly And Company | Nucleic acids, vectors, host cells, polypeptides and uses thereof |
| CA2705366A1 (en) | 2000-08-28 | 2002-03-07 | Agensys, Inc. | Nucleic acid and corresponding protein entitled 85p1b3 useful in treatment and detection of cancer |
| EP1313761A4 (en) * | 2000-08-28 | 2005-01-26 | Human Genome Sciences Inc | 18 human secreted proteins |
| WO2002018568A2 (en) * | 2000-08-28 | 2002-03-07 | Astrazeneca Ab | Molecules involved in the regulation of insulin in resistance syndrome (irs) |
| AU2001286815A1 (en) * | 2000-08-30 | 2002-03-13 | Millennium Pharmaceuticals, Inc. | 48921, a novel human gtp releasing factor and uses therefor |
| WO2002018573A2 (en) * | 2000-08-30 | 2002-03-07 | Millennium Pharmaceuticals, Inc. | 54370, a novel human sulfate transporter and uses therefor |
| AU2002210464A1 (en) * | 2000-08-30 | 2002-03-13 | Bayer Aktiengesellschaft | Regulation of human aminotransferase-like enzyme |
| WO2002018552A2 (en) * | 2000-08-30 | 2002-03-07 | Bayer Aktiengesellschaft | Regulation of human aminotransferase-like enzyme |
| AU2001288600A1 (en) | 2000-08-31 | 2002-03-13 | Millennium Pharmaceuticals, Inc. | 62112, a novel human dehydrogenase and uses thereof |
| ATE431405T1 (en) | 2000-09-05 | 2009-05-15 | Amgen Inc | TNF RECEPTOR-LIKE MOLECULES AND THEIR APPLICATIONS |
| EP1364015A2 (en) * | 2000-09-05 | 2003-11-26 | Incyte Genomics, Inc. | Molecules for diagnostics and therapeutics |
| WO2002020765A2 (en) * | 2000-09-08 | 2002-03-14 | Millennium Pharmaceuticals, Inc. | 38646, a guanine nucleotide exchange factor and uses therefor |
| US6372468B1 (en) * | 2000-09-14 | 2002-04-16 | Pe Corporation (Ny) | Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| US6391606B1 (en) * | 2000-09-14 | 2002-05-21 | Pe Corporation | Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses thereof |
| WO2002029058A2 (en) * | 2000-10-05 | 2002-04-11 | Curagen Corporation | Human proteins, polynucleotides encoding them and methods of using the same |
| AU2002211597A1 (en) * | 2000-10-11 | 2002-04-22 | Millennium Pharmaceuticals, Inc. | 8843, a human dual specificity phosphatase family member and uses therefor |
| AU2002220613A1 (en) * | 2000-10-11 | 2002-04-22 | Bayer Aktiengesellschaft | Regulation of human cyclophilin-type peptidyl-prolyl cis-trans isomerase |
| US20020064831A1 (en) * | 2000-10-12 | 2002-05-30 | The Texas A&M University System | Nucleic acid sequences encoding CMG proteins, CMG proteins, and methods for their use |
| WO2002030268A2 (en) * | 2000-10-13 | 2002-04-18 | Eos Biotechnology, Inc. | Methods of diagnosis of prostate cancer, compositions and methods of screening for modulators of prostate cancer |
| US6531297B2 (en) * | 2000-10-20 | 2003-03-11 | Applera Corporation | Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
| AU2002249787A1 (en) | 2000-10-25 | 2002-08-19 | Diadexus, Inc. | Compositions and methods relating to lung specific genes and proteins |
| WO2002036781A2 (en) * | 2000-10-31 | 2002-05-10 | Bayer Aktiengesellschaft | Regulation of human glutathione-s-transferase |
| WO2002038743A2 (en) * | 2000-11-09 | 2002-05-16 | Glaxo Group Limited | Deaminase catalyzing the removal of the cyclopropyl moiety from abacavir-mp |
| US6855517B2 (en) | 2000-11-20 | 2005-02-15 | Diadexus, Inc. | Compositions and methods relating to breast specific genes and proteins |
| WO2002081667A2 (en) * | 2000-12-05 | 2002-10-17 | Incyte Genomics, Inc. | Ligases |
| US7776523B2 (en) | 2000-12-07 | 2010-08-17 | Novartis Vaccines And Diagnostics, Inc. | Endogenous retroviruses up-regulated in prostate cancer |
| WO2002046417A2 (en) | 2000-12-07 | 2002-06-13 | Zymogenetics, Inc. | Adipocyte complement related protein zacrp3x2 |
| AU2002211305A1 (en) * | 2000-12-14 | 2002-06-24 | Pe Corporation (Ny) | Isolated human kinase proteins, their encoding nucleic acid molecules, and uses thereof |
| US20020142376A1 (en) * | 2000-12-20 | 2002-10-03 | Gennady Merkulov | Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| US7892730B2 (en) * | 2000-12-22 | 2011-02-22 | Sagres Discovery, Inc. | Compositions and methods for cancer |
| CA2432867A1 (en) | 2000-12-22 | 2002-08-08 | Bristol-Myers Squibb Company | A novel human leucine-rich repeat containing protein expressed predominately in small intestine, hlrrsi1 |
| US6423521B1 (en) | 2000-12-28 | 2002-07-23 | Pe Corporation (Ny) | Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| WO2002053591A1 (en) * | 2000-12-30 | 2002-07-11 | Lion Bioscience Ag | Mammalian nuclear receptor cofactor cf12 and methods of use |
| WO2002053754A2 (en) * | 2001-01-08 | 2002-07-11 | Lexicon Genetics Incorporated | Human protease and polynucleotides encoding the same |
| WO2002061046A2 (en) * | 2001-01-30 | 2002-08-08 | Regeneron Pharmaceuticals, Inc. | Novel nucleic acid and polypeptide molecules |
| EP1409536A2 (en) * | 2001-02-12 | 2004-04-21 | Curagen Corporation | Human proteins and nucleic acids encoding same |
| EP1637601A3 (en) * | 2001-02-21 | 2006-03-29 | Curagen Corporation | Proteins, polynucleotides encoding them and methods of using the same |
| US7271240B2 (en) | 2001-03-14 | 2007-09-18 | Agensys, Inc. | 125P5C8: a tissue specific protein highly expressed in various cancers |
| WO2002074906A2 (en) * | 2001-03-16 | 2002-09-26 | Eli Lilly And Company | Lp mammalian proteins; related reagents |
| US6913904B2 (en) * | 2001-03-27 | 2005-07-05 | Applera Corporation | Isolated human Ras-like proteins, nucleic acid molecules encoding these human Ras-like proteins, and uses thereof |
| AU2002258626B2 (en) | 2001-04-10 | 2007-01-18 | Agensys, Inc. | Nucleid acid and corresponding protein entitled 158P3D2 useful in treatment and detection of cancer |
| ATE512216T1 (en) | 2001-04-10 | 2011-06-15 | Agensys Inc | NUCLEIC ACID AND THIS CORRESPONDING PROTEIN, CALLED 184P1E2, SUITABLE FOR THE TREATMENT AND DETECTION OF CANCER |
| EP2280030A3 (en) | 2001-04-10 | 2011-06-15 | Agensys, Inc. | Nucleic acids and corresponding proteins useful in the detection and treatment of various cancers |
| WO2002088175A1 (en) * | 2001-04-24 | 2002-11-07 | Otsuka Pharmaceutical Co., Ltd. | Crohn's disease antibody-binding peptide and method of examining crohn's disease |
| CA2483507A1 (en) * | 2001-04-24 | 2002-10-31 | Isis Innovation Limited | Enzyme and snp marker for disease |
| WO2002090546A1 (en) * | 2001-05-07 | 2002-11-14 | Shionogi & Co., Ltd. | Polypeptide serving as angiogenic marker and dna thereof |
| WO2002090543A2 (en) * | 2001-05-09 | 2002-11-14 | Bayer Aktiengesellschaft | Regulation of human phosphatidic acid phosphatase type 2c-like protein |
| US7235358B2 (en) * | 2001-06-08 | 2007-06-26 | Expression Diagnostics, Inc. | Methods and compositions for diagnosing and monitoring transplant rejection |
| US6905827B2 (en) | 2001-06-08 | 2005-06-14 | Expression Diagnostics, Inc. | Methods and compositions for diagnosing or monitoring auto immune and chronic inflammatory diseases |
| AU2002311535A1 (en) * | 2001-06-26 | 2003-01-08 | Decode Genetics Ehf. | Nucleic acids encoding protein kinases |
| US20030120040A1 (en) | 2001-06-29 | 2003-06-26 | Genentech, Inc. | Secreted and Transmembrane polypeptides and nucleic acids encoding the same |
| GB2399086A (en) * | 2001-08-02 | 2004-09-08 | Aeomica Inc | Human zinc finger containing gene MDZ4 |
| EP1423415A4 (en) * | 2001-08-17 | 2005-04-06 | Incyte Genomics Inc | Intracellular signaling molecules |
| US7270960B2 (en) | 2001-08-29 | 2007-09-18 | Pacific Northwest Research Institute | Diagnosis of ovarian carcinomas |
| WO2003023063A1 (en) * | 2001-09-07 | 2003-03-20 | Sankyo Company, Limited | Method of judging onset risk of diabetes |
| WO2003040369A2 (en) * | 2001-09-17 | 2003-05-15 | Molecular Engines Laboratories | Sequences involved in tumoral suppression, tumoral reversion, apoptosis and/or viral resistance phenomena and their use as medicines |
| WO2003025175A2 (en) * | 2001-09-17 | 2003-03-27 | Molecular Engines Laboratories | Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines |
| CA2417455C (en) | 2001-09-28 | 2008-01-29 | Brigham Young University | Novel cyclooxygenase variants and methods of use |
| US20040248132A1 (en) | 2001-10-04 | 2004-12-09 | Toshiyuki Sakai | DR5 gene promoter and siah-1 gene promoter |
| US7084257B2 (en) | 2001-10-05 | 2006-08-01 | Amgen Inc. | Fully human antibody Fab fragments with human interferon-gamma neutralizing activity |
| WO2003031607A1 (en) * | 2001-10-10 | 2003-04-17 | Bayer Healthcare Ag | Regulation of human short-chain dehydrogenase/reductase |
| ATE364690T1 (en) | 2001-11-09 | 2007-07-15 | Proteologics Inc | POSH NUCLEIC ACID, POLYPEPTIDES AND RELATED METHODS |
| US7491690B2 (en) | 2001-11-14 | 2009-02-17 | Northwestern University | Self-assembly and mineralization of peptide-amphiphile nanofibers |
| WO2003044197A1 (en) * | 2001-11-21 | 2003-05-30 | Japan Science And Technology Agency | Huntington’s disease gene transcriptional factors |
| US7151162B2 (en) | 2001-12-06 | 2006-12-19 | The University Of Children's Hospital Of Both Cantons Of Basel | Nuclear protein |
| AU2002339697A1 (en) * | 2001-12-19 | 2003-06-30 | Genset S.A. | Gmg-5 polynucleotides and polypeptides and uses thereof |
| JP2003245084A (en) * | 2001-12-20 | 2003-09-02 | Morinaga Milk Ind Co Ltd | New gene useful for diagnosis and treatment of aplasia of corpus callosum and aspermatogenesis and use thereof |
| DE10163467A1 (en) * | 2001-12-21 | 2003-11-27 | Axaron Bioscience Ag | New DNA sequence encoding protein 24B2, useful for treatment and diagnosis or cancer and degenerative diseases, also related polypeptides and modulators |
| US6759222B2 (en) | 2002-01-02 | 2004-07-06 | Millennium Pharmaceuticals, Inc. | 14815, a human kinase family member and uses therefor |
| AU2003202543A1 (en) * | 2002-01-07 | 2003-07-24 | Bayer Aktiengesellschaft | Human phosphatidic acid phosphatase type 2-like protein |
| AU2003205611A1 (en) * | 2002-01-15 | 2003-07-30 | Medigene Ag | Dilated cardiomyopathy associated gene-2 (dcmag-2): a cytoplasmatic inducer of sarcomeric remodeling in cardiomyocytes |
| WO2003060109A2 (en) * | 2002-01-15 | 2003-07-24 | Bayer Healthcare Ag | Human subtilisin/kexin-like convertase |
| JPWO2003062429A1 (en) * | 2002-01-23 | 2005-05-26 | 山之内製薬株式会社 | New serine protease |
| US7371719B2 (en) | 2002-02-15 | 2008-05-13 | Northwestern University | Self-assembly of peptide-amphiphile nanofibers under physiological conditions |
| EP1338609A1 (en) * | 2002-02-21 | 2003-08-27 | MEMOREC Stoffel GmbH-Medizinisch-Molekulare Entwicklung, Köln | A further KDR receptor and the use thereof |
| CA2478271A1 (en) * | 2002-03-05 | 2003-09-18 | Applera Corporation | Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| AU2003208472A1 (en) * | 2002-03-06 | 2003-09-16 | Oxford Glycosciences (Uk) Ltd | Novel b-cell malignancy-associated protein |
| DK2261369T3 (en) | 2002-03-13 | 2014-07-28 | Genomic Health Inc | Gene expression profiling in tumor tissue biopsies |
| JP3949111B2 (en) * | 2002-03-19 | 2007-07-25 | 田辺製薬株式会社 | Novel G protein-coupled receptor and gene thereof |
| US7527935B2 (en) | 2002-03-19 | 2009-05-05 | Mitsubishi Tanabe Pharma Corporation | G-protein coupled receptor having eicosanoid as ligand and gene thereof |
| GB0206684D0 (en) * | 2002-03-21 | 2002-05-01 | Babraham Inst | Novel proteins |
| US7193069B2 (en) | 2002-03-22 | 2007-03-20 | Research Association For Biotechnology | Full-length cDNA |
| US7329502B2 (en) | 2002-04-25 | 2008-02-12 | The United States Of America As Represented By The Department Of Health And Human Services | ZAP-70 expression as a marker for chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) |
| JP2004041003A (en) * | 2002-05-17 | 2004-02-12 | Takeda Chem Ind Ltd | New protein, its dna and use thereof |
| EP2275118A3 (en) | 2002-05-29 | 2011-10-19 | DeveloGen Aktiengesellschaft | Pancreas-specific proteins |
| US7198899B2 (en) | 2002-06-03 | 2007-04-03 | Chiron Corporation | Use of NRG4, or inhibitors thereof, in the treatment of colon and pancreatic cancers |
| BRPI0311822B8 (en) | 2002-06-06 | 2021-05-25 | Oncotherapy Science Inc | pharmaceutical composition for the treatment of cancer |
| AU2003276679A1 (en) | 2002-06-13 | 2003-12-31 | Chiron Corporation | Vectors for expression of hml-2 polypeptides |
| JPWO2004009626A1 (en) * | 2002-07-22 | 2005-11-17 | アステラス製薬株式会社 | Rheumatoid arthritis-related novel gene |
| EP1551976B1 (en) | 2002-08-14 | 2008-12-31 | National Institue of Advanced Industrial Science and Technology | Novel n-acetylgalactosamine transferases and nucleic acids encoding the same |
| AU2003243151A1 (en) * | 2002-08-16 | 2004-03-03 | Agensys, Inc. | Nucleic acid and corresponding protein entitled 251p5g2 useful in treatment and detection of cancer |
| WO2004018518A1 (en) * | 2002-08-23 | 2004-03-04 | Japan Science And Technology Agency | Human solid cancer antigen peptides, polynucleotides encoding the same and utilization thereof |
| WO2004020662A2 (en) * | 2002-08-27 | 2004-03-11 | Epigenomics Ag | Method and nucleic acids for the analysis of breast cell proliferative disorders |
| US7452969B2 (en) | 2002-08-30 | 2008-11-18 | Licentia Ltd | Neurotrophic factor protein and uses thereof |
| ES2320443T3 (en) * | 2002-09-30 | 2009-05-22 | Oncotherapy Science, Inc. | GENES AND POLYPEPTIDES RELATED TO HUMAN PANCREATIC CANCERS. |
| AU2003294696A1 (en) * | 2002-10-17 | 2004-05-04 | Evotec Neurosciences Gmbh | Diagnostic and therapeutic use of the nicotinamide mononucleotide adenylytransferase 2 (nmnat-2) gene and protein for neurodegenerative diseases |
| AU2002952216A0 (en) * | 2002-10-23 | 2002-11-07 | The Walter And Eliza Hall Institute Of Medical Research | Novel therapeutic molecules |
| US7554021B2 (en) | 2002-11-12 | 2009-06-30 | Northwestern University | Composition and method for self-assembly and mineralization of peptide amphiphiles |
| AU2003295598B2 (en) | 2002-11-15 | 2009-12-24 | Genomic Health, Inc. | Gene expression profiling of EGFR positive cancer |
| DE10254601A1 (en) | 2002-11-22 | 2004-06-03 | Ganymed Pharmaceuticals Ag | Gene products differentially expressed in tumors and their use |
| AU2002953341A0 (en) * | 2002-12-13 | 2003-01-09 | The Walter And Eliza Hall Institute Of Medical Research | A novel phosphoprotein |
| AU2003287764B2 (en) * | 2002-12-13 | 2010-01-21 | The Walter And Eliza Hall Institute Of Medical Research | A novel phosphoprotein |
| US20040231909A1 (en) | 2003-01-15 | 2004-11-25 | Tai-Yang Luh | Motorized vehicle having forward and backward differential structure |
| WO2004070025A2 (en) * | 2003-02-05 | 2004-08-19 | Juan Saus | Novel goodpasture antigen-binding protein isoforms and protein misfolded-mediated disorders |
| EP1445614A1 (en) * | 2003-02-06 | 2004-08-11 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | A method for the in vitro assessment of the progression status of an HIV virus in an invidual |
| US7074891B2 (en) | 2003-02-07 | 2006-07-11 | Posco | Leukocyte stimulating peptides |
| ES2314378T3 (en) | 2003-02-20 | 2009-03-16 | Genomic Health, Inc. | USE OF INTRONIC RNA TO MEASURE GENE EXPRESSION. |
| CA2517953A1 (en) * | 2003-03-04 | 2004-09-16 | Astellas Pharma Inc. | Novel gene relating to fibrotic conditions |
| PL2248899T3 (en) | 2003-03-19 | 2015-10-30 | Biogen Ma Inc | NOGO receptor binding protein |
| ITRM20030149A1 (en) | 2003-04-02 | 2004-10-03 | Giuliani Spa | ANTISENSE OLIGONUCLEOTIDES (ODN) FOR SMAD7 AND THEIR USE IN THE MEDICAL FIELD |
| CA3061769C (en) | 2003-06-24 | 2021-10-26 | Genomic Health, Inc. | Methods of predicting the likelihood of long-term survival of a human patient with node-negative, estrogen receptor (er) positive, invasive ductal breast cancer without the recurrence of breast cancer |
| DK1644858T3 (en) | 2003-07-10 | 2018-01-22 | Genomic Health Inc | Functional clothing with at least one outer layer and inner membrane. |
| EP2311468B1 (en) | 2003-08-08 | 2014-01-15 | Perseus Proteomics Inc. | Gene overexpressed in cancer |
| US20050136434A1 (en) * | 2003-08-12 | 2005-06-23 | Mai Xu | Isolated heat-inducible cell surface protein and hyperthermia-based tumor immunotargeting therapy |
| US20070178458A1 (en) * | 2003-09-05 | 2007-08-02 | O'brien Philippa | Methods of diagnosis and prognosis of ovarian cancer II |
| WO2005026314A2 (en) * | 2003-09-10 | 2005-03-24 | Japan Science And Technology Agency | Group of genes differentially expressed in peripheral blood cells and diagnostic method and assay method using the same |
| DE602004028262D1 (en) * | 2003-10-02 | 2010-09-02 | Glaxosmithkline Biolog Sa | B. PERTUSSIS ANTIGENE AND ITS USE IN VACCINATION |
| BRPI0414924A (en) | 2003-10-03 | 2006-11-07 | Brigham & Womens Hospital | tim-3 ligands and their methods |
| WO2005040791A2 (en) * | 2003-10-21 | 2005-05-06 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with somatostatin- and angiogenin-like peptide receptor (salpr) |
| US20050255560A1 (en) * | 2003-11-21 | 2005-11-17 | Zeren Gao | Ztnf11, a tumor necrosis factor |
| US7544661B2 (en) * | 2003-12-05 | 2009-06-09 | Northwestern University | Self-assembling peptide amphiphiles and related methods for growth factor delivery |
| DE602004031368D1 (en) | 2003-12-23 | 2011-03-24 | Genomic Health Inc | UNIVERSAL REPRODUCTION OF FRAGMENTED RNA |
| US20050186577A1 (en) | 2004-02-20 | 2005-08-25 | Yixin Wang | Breast cancer prognostics |
| EP3556866B1 (en) * | 2004-03-02 | 2021-04-07 | The Johns Hopkins University | Mutations of the pik3ca gene in human cancers |
| TW200539890A (en) | 2004-03-12 | 2005-12-16 | Brigham & Womens Hospital | Methods of modulating immune responses by modulating tim-1, tim-2 and tim-4 function |
| WO2005090569A1 (en) * | 2004-03-24 | 2005-09-29 | The Council Of The Queensland Institute Of Medical Research | Cancer and testis vsm1 and vsm2 nucleic acids, proteins and uses thereof |
| KR101204286B1 (en) * | 2004-03-30 | 2012-11-26 | 엔에스진 에이/에스 | Therapeutic use of a growth factor, NsG33 |
| WO2005100606A2 (en) | 2004-04-09 | 2005-10-27 | Genomic Health, Inc. | Gene expression markers for predicting response to chemotherapy |
| DE102004024617A1 (en) | 2004-05-18 | 2005-12-29 | Ganymed Pharmaceuticals Ag | Differentially expressed in tumors gene products and their use |
| WO2005118832A2 (en) * | 2004-06-01 | 2005-12-15 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with serum/glucocorticoid regulated kinase-like protein (sgkl) |
| ES2395094T3 (en) | 2004-06-24 | 2013-02-08 | Biogen Idec Ma Inc. | Treatment of conditions that involve demyelination |
| US7587279B2 (en) | 2004-07-06 | 2009-09-08 | Genomic Health | Method for quantitative PCR data analysis system (QDAS) |
| WO2006013661A1 (en) * | 2004-08-05 | 2006-02-09 | Toagosei Co., Ltd. | Crohn’s disease antibody epitope peptide and reagent for testing crohn’s disease |
| US7622251B2 (en) | 2004-11-05 | 2009-11-24 | Genomic Health, Inc. | Molecular indicators of breast cancer prognosis and prediction of treatment response |
| AU2005304824B2 (en) | 2004-11-05 | 2011-12-22 | Genomic Health, Inc. | Predicting response to chemotherapy using gene expression markers |
| EP2325207B1 (en) | 2004-11-12 | 2017-03-15 | Xencor, Inc. | FC variants with altered binding to FCRN |
| US8367805B2 (en) | 2004-11-12 | 2013-02-05 | Xencor, Inc. | Fc variants with altered binding to FcRn |
| JP2008531733A (en) | 2005-03-04 | 2008-08-14 | ノースウエスタン ユニバーシティ | Angiogenic heparin-binding epitopes, peptide amphiphiles, self-assembling compositions, and related uses |
| US8497101B2 (en) * | 2005-05-13 | 2013-07-30 | Centre National De La Recherche Scientifique (Cnrs) | Use of a new gene coding for a new member of the MCM2-8 family in pharmaceutical compositions |
| PL1904104T3 (en) | 2005-07-08 | 2014-02-28 | Biogen Ma Inc | Sp35 antibodies and uses thereof |
| WO2007014338A2 (en) * | 2005-07-26 | 2007-02-01 | Siemens Medical Solutions Diagnostics | Single nucleotide polymorphisms associated with susceptibility to cardiovascular disease |
| US8207128B2 (en) * | 2005-09-28 | 2012-06-26 | Supadelixir Inc. | Polypeptide inhibiting transmigration of leukocytes or growth and/or metastasis of cancer cells, and fusion protein thereof |
| EP1790664A1 (en) | 2005-11-24 | 2007-05-30 | Ganymed Pharmaceuticals AG | Monoclonal antibodies against claudin-18 for treatment of cancer |
| CA2633468C (en) | 2005-12-14 | 2014-02-18 | Licentia Ltd | Novel neurotrophic factor protein and uses thereof |
| JP2009540852A (en) * | 2006-07-03 | 2009-11-26 | エグゾニ・テラピューティック・ソシエテ・アノニム | Prostate-specific transcripts and their use in the treatment and diagnosis of prostate cancer |
| US20080108070A1 (en) * | 2006-09-08 | 2008-05-08 | Corixa Corporation | Methods, compositions, and kits for the detection and monitoring of colon cancer |
| US8076295B2 (en) | 2007-04-17 | 2011-12-13 | Nanotope, Inc. | Peptide amphiphiles having improved solubility and methods of using same |
| US8999634B2 (en) * | 2007-04-27 | 2015-04-07 | Quest Diagnostics Investments Incorporated | Nucleic acid detection combining amplification with fragmentation |
| GB0805159D0 (en) * | 2008-03-19 | 2008-04-23 | Sancho Madrid David | Immune modulation via C-type lectin |
| ES2555282T3 (en) * | 2007-07-27 | 2015-12-30 | Immatics Biotechnologies Gmbh | New immunogenic epitopes for immunotherapy |
| US7863021B2 (en) | 2007-09-05 | 2011-01-04 | Celera Corporation | Genetic polymorphisms associated with rheumatoid arthritis, methods of detection and uses thereof |
| WO2009034661A1 (en) * | 2007-09-12 | 2009-03-19 | Toppan Printing Co., Ltd. | Method for diagnosis and induction of resistance to virus |
| ES2401233T3 (en) | 2007-10-17 | 2013-04-18 | Universidad de Córdoba | Isoforms of the human somatostatin type 5 receptor produced by alternative treatment and oligonucleotide pairs for their detection by PCR |
| EP2808343B8 (en) | 2007-12-26 | 2020-01-15 | Xencor, Inc. | Fc variants with altered binding to FcRn |
| GB0803352D0 (en) * | 2008-02-22 | 2008-04-02 | Ntnu Technology Transfer As | Oligopeptidic compounds and uses thereof |
| US9683031B2 (en) | 2008-03-21 | 2017-06-20 | Universiteit Hasselt | Biomarkers for rheumatoid arthritis |
| US8058406B2 (en) | 2008-07-09 | 2011-11-15 | Biogen Idec Ma Inc. | Composition comprising antibodies to LINGO or fragments thereof |
| CN102164611B (en) | 2008-07-24 | 2015-01-07 | Ns基因公司 | Therapeutic use of a growth factor, METRNL |
| DK2172211T3 (en) | 2008-10-01 | 2015-02-16 | Immatics Biotechnologies Gmbh | Composition of tumor-associated peptides and related anti-cancer vaccine for the treatment of glioblastoma (GBM) and other cancers |
| AU2009313808B2 (en) | 2008-11-14 | 2013-05-16 | Gen-Probe Incorporated | Compositions, kits and methods for detection of campylobacter nucleic acid |
| US20110229471A1 (en) | 2008-11-26 | 2011-09-22 | Cedars-Sinai Medical Center | Methods of determining responsiveness to anti-tnf alpha therapy in inflammatory bowel disease |
| CA2745849A1 (en) * | 2008-12-09 | 2010-06-17 | Alethia Biotherapeutics Inc. | Novel human endogenous retorviral erv3 variant and uses thereof for diagnosing ovarian cancer |
| WO2010120830A1 (en) | 2009-04-13 | 2010-10-21 | Northwestern University | Novel peptide-based scaffolds for cartilage regeneration and methods for their use |
| WO2011028952A1 (en) | 2009-09-02 | 2011-03-10 | Xencor, Inc. | Compositions and methods for simultaneous bivalent and monovalent co-engagement of antigens |
| JP6210685B2 (en) | 2010-01-27 | 2017-10-11 | マサチューセッツ インスティテュート オブ テクノロジー | Engineered polypeptide agents for targeted broad spectrum influenza neutralization |
| AU2011312417B2 (en) | 2010-09-29 | 2015-08-20 | Agensys, Inc. | Antibody drug conjugates (ADC) that bind to 191P4D12 proteins |
| CN103269708A (en) | 2010-10-01 | 2013-08-28 | Ns基因公司 | Use of meteorin for the treatment of allodynia, hyperalgesia, spontaneous pain and phantom pain |
| WO2012081040A1 (en) * | 2010-12-14 | 2012-06-21 | Hananja Ehf. | Biological activity of placental protein 13 |
| CN104105501B (en) | 2011-09-05 | 2017-10-20 | 霍巴治疗公司 | Allodynia, hyperalgia, the treatment of spontaneous pain and phantom pain |
| AR088699A1 (en) * | 2011-11-09 | 2014-06-25 | Sanofi Sa | DIACILGLICEROL LIPASA AND USES OF THE SAME |
| CN108503711A (en) | 2012-04-30 | 2018-09-07 | 比奥孔有限公司 | Targeting/immune regulative fusion protein and its manufacturing method |
| WO2013167153A1 (en) | 2012-05-09 | 2013-11-14 | Ganymed Pharmaceuticals Ag | Antibodies useful in cancer diagnosis |
| MX2014013950A (en) | 2012-05-14 | 2015-02-17 | Biogen Idec Inc | Lingo-2 antagonists for treatment of conditions involving motor neurons. |
| WO2013174404A1 (en) | 2012-05-23 | 2013-11-28 | Ganymed Pharmaceuticals Ag | Combination therapy involving antibodies against claudin 18.2 for treatment of cancer |
| US10093736B2 (en) | 2012-11-13 | 2018-10-09 | Biontech Ag | Agents for treatment of claudin expressing cancer diseases |
| WO2014127785A1 (en) | 2013-02-20 | 2014-08-28 | Ganymed Pharmaceuticals Ag | Combination therapy involving antibodies against claudin 18.2 for treatment of cancer |
| US9023353B2 (en) * | 2013-03-13 | 2015-05-05 | The Board Of Trustees Of The University Of Arkansas | Anti-(+)—methamphetamine monoclonal antibodies |
| WO2014146672A1 (en) | 2013-03-18 | 2014-09-25 | Ganymed Pharmaceuticals Ag | Therapy involving antibodies against claudin 18.2 for treatment of cancer |
| EP2978440B1 (en) | 2013-03-27 | 2019-10-02 | Cedars-Sinai Medical Center | Treating fibrosis by inhibiting tl1a and diagnosing fibrosis by detecting il31ra |
| JP7019233B2 (en) | 2013-07-11 | 2022-02-15 | モデルナティエックス インコーポレイテッド | Compositions and Methods of Use Containing Synthetic polynucleotides and Synthetic sgRNAs Encoding CRISPR-Related Proteins |
| WO2015010108A1 (en) | 2013-07-19 | 2015-01-22 | Cedars-Sinai Medical Center | Signature of tl1a (tnfsf15) signaling pathway |
| CN118146306A (en) | 2013-09-25 | 2024-06-07 | 西托姆克斯治疗公司 | Matrix metalloproteinase substrates and other cleavable moieties and methods of use thereof |
| EP3053592A4 (en) | 2013-10-01 | 2017-09-06 | Mie University | T cell-inducing vaccine containing interepitope sequence promoting antigen presentation |
| NZ722401A (en) | 2014-01-31 | 2023-06-30 | Cytomx Therapeutics Inc | Matriptase and u-plasminogen activator substrates and other cleavable moieties and methods of use thereof |
| MX2017009038A (en) | 2015-01-08 | 2017-10-25 | Biogen Ma Inc | Lingo-1 antagonists and uses for treatment of demyelinating disorders. |
| MA41374A (en) | 2015-01-20 | 2017-11-28 | Cytomx Therapeutics Inc | MATRIX METALLOPROTEASE CLIVABLE AND SERINE PROTEASE CLIVABLE SUBSTRATES AND METHODS OF USE THEREOF |
| US11124766B2 (en) * | 2015-06-12 | 2021-09-21 | Emory University | Growth and survival compositions for cells capable of producing antibodies and methods related thereto |
| EP3344776B1 (en) * | 2015-09-04 | 2021-06-16 | Synthetic Genomics, Inc. | Rekombinant algal microorganism with increased productivity |
| KR20240095481A (en) | 2016-03-17 | 2024-06-25 | 세다르스-신나이 메디칼 센터 | Methods of diagnosing inflammatory bowel disease through rnaset2 |
| CN109475624A (en) * | 2016-03-29 | 2019-03-15 | 瓦尔基里治疗有限公司 | The adjusting that the structure that chromosome -1 is expressed maintains |
| US9611297B1 (en) | 2016-08-26 | 2017-04-04 | Thrasos Therapeutics Inc. | Compositions and methods for the treatment of cast nephropathy and related conditions |
| US11125757B2 (en) | 2017-05-26 | 2021-09-21 | Emory University | Methods of culturing and characterizing antibody secreting cells |
| EP3508499A1 (en) | 2018-01-08 | 2019-07-10 | iOmx Therapeutics AG | Antibodies targeting, and other modulators of, an immunoglobulin gene associated with resistance against anti-tumour immune responses, and uses thereof |
| KR20210102318A (en) | 2018-12-06 | 2021-08-19 | 싸이톰스 테라퓨틱스, 인크. | Matrix metalloprotease-cleavable substrates and serine or cysteine protease-cleavable substrates and methods of use thereof |
| AU2020261435A1 (en) * | 2019-04-26 | 2021-11-25 | Sangamo Therapeutics, Inc. | Engineering AAV |
| CN114401992A (en) | 2019-07-05 | 2022-04-26 | 艾欧麦克斯治疗股份公司 | Antibodies to IGSF11(VSIG3) that bind IGC2 and uses thereof |
| WO2021083958A1 (en) * | 2019-10-29 | 2021-05-06 | Specialites Pet Food | Novel peptides inducing satiety |
| AU2021244056B2 (en) * | 2020-03-27 | 2024-04-04 | Onecuregen Co., Ltd. | Composition comprising VGLL1 peptide for treatment of cancer |
| US20230212243A1 (en) * | 2020-05-12 | 2023-07-06 | Institut Curie | Neoantigenic Epitopes Associated with SF3B1 Mutations |
| US20240010720A1 (en) | 2020-07-06 | 2024-01-11 | Iomx Therapeutics Ag | Antibodies binding igv of igsf11 (vsig3) and uses thereof |
| AU2022209669A1 (en) * | 2021-01-21 | 2023-08-10 | Erasmus University Medical Center Rotterdam | T cells for use in therapy |
| JP2024509376A (en) * | 2021-02-18 | 2024-03-01 | ベレン セラピューティクス ピー．ビー．シー． | Treatment of familial heterozygous and homozygous hypercholesterolemia with cyclodextrin |
| WO2023225602A1 (en) * | 2022-05-20 | 2023-11-23 | Medikine, Inc. | Interleukin-18 receptor binding polypeptides and uses thereof |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4446240A (en) * | 1981-01-30 | 1984-05-01 | Nerenberg Samuel T | Pancreas specific protein systems |
| US5457038A (en) * | 1988-11-10 | 1995-10-10 | Genetics Institute, Inc. | Natural killer stimulatory factor |
| US6080540A (en) * | 1990-04-20 | 2000-06-27 | Cold Spring Harbor Laboratory | Cloning of mammalian genes in microbial organisms and methods for pharmacological screening |
| EP0559770A4 (en) * | 1990-11-26 | 1995-04-05 | Us Commerce | Cell stress transcriptional factors |
| US5721352A (en) * | 1991-02-19 | 1998-02-24 | University Of Florida Research Foundation | Entomopoxvirus expression system |
| US5840870A (en) * | 1995-12-29 | 1998-11-24 | Incyte Pharmaceuticals, Inc. | Polynucleotides PANC1A and PANC1B associated with pancreatic cancer |
| WO1997007827A1 (en) * | 1995-08-22 | 1997-03-06 | Thomas Jefferson University | Gab1, A Grb2 BINDING PROTEIN, AND COMPOSITIONS FOR MAKING AND METHODS OF USING THE SAME |
| JP3462313B2 (en) * | 1995-08-24 | 2003-11-05 | キッコーマン株式会社 | Mutant uricase, mutant uricase gene, novel recombinant DNA, and method for producing mutant uricase |
| US5998165A (en) * | 1995-12-29 | 1999-12-07 | Incyte Pharmaceuticals, Inc. | Polynucleotides encoding a protein associated with pancreatic cancer |
| CA2253433A1 (en) * | 1996-04-29 | 1997-11-06 | The Johns Hopkins University School Of Medicine | Mammalian regulator of nonsense-mediated rna decay |
| US6500934B1 (en) * | 1996-07-24 | 2002-12-31 | Michael Rush Lerner | Bivalent agonists for G-protein coupled receptors |
| US5976834A (en) * | 1997-01-09 | 1999-11-02 | Smithkline Beecham Corporation | cDNA clone HNFJD15 that encodes a novel human 7-transmembrane receptor |
| US5925521A (en) * | 1997-03-31 | 1999-07-20 | Incyte Pharmaceuticals, Inc. | Human serine carboxypeptidase |
| CA2232743A1 (en) * | 1997-04-02 | 1998-10-02 | Smithkline Beecham Corporation | A tnf homologue, tl5 |
| JP2001519666A (en) * | 1997-04-10 | 2001-10-23 | ジェネティックス・インスチチュート・インコーポレーテッド | Secretory expression sequence tags (sESTs) |
| IT1291110B1 (en) * | 1997-04-15 | 1998-12-29 | Istituto Europ Di Oncologia S | INTRACELLULAR INTERACTORS AND BINDING SPECIFICITY OF THE DOMAIN EH |
| US5948641A (en) * | 1997-05-29 | 1999-09-07 | Incyte Pharmaceuticals, Inc. | Polynucleotides encoding a metal response element binding protein |
| WO1998055620A1 (en) * | 1997-06-06 | 1998-12-10 | Regeneron Pharmaceuticals, Inc. | Ntn-2 member of tnf ligand family |
| AU9484398A (en) * | 1997-09-17 | 1999-04-05 | Genentech Inc. | Promotion or inhibition of angiogenesis and cardiovascularization |
| US5932442A (en) * | 1997-09-23 | 1999-08-03 | Incyte Pharmaceuticals, Inc. | Human regulatory molecules |
| US5972660A (en) * | 1997-10-22 | 1999-10-26 | Incyte Pharmaceuticals, Inc. | Human hydroxypyruvate reductase |
| DE19818598A1 (en) * | 1998-04-19 | 1999-10-21 | Metagen Gesellschaft Fuer Genomforschung Mbh | New nucleic acid sequences expressed in normal pancreatic tissues, and derived polypeptides, for treatment of pancreatic cancer and identification of therapeutic agents |
| WO1999055865A1 (en) * | 1998-04-29 | 1999-11-04 | Genesis Research And Development Corporation Limited | Polynucleotides isolated from skin cells and methods for their use |
| US6262249B1 (en) * | 1998-06-23 | 2001-07-17 | Chiron Corporation | Pancreatic cancer genes |
| CA2296792A1 (en) * | 1999-02-26 | 2000-08-26 | Genset S.A. | Expressed sequence tags and encoded human proteins |
-
2001
- 2001-01-17 CA CA002395827A patent/CA2395827A1/en not_active Withdrawn
- 2001-01-17 WO PCT/US2001/001356 patent/WO2001055173A2/en not_active Application Discontinuation
- 2001-01-17 WO PCT/US2001/001342 patent/WO2001059064A2/en active Search and Examination
- 2001-01-17 CA CA002393652A patent/CA2393652A1/en not_active Withdrawn
- 2001-01-17 WO PCT/US2001/001315 patent/WO2001055311A2/en active Search and Examination
- 2001-01-17 WO PCT/US2001/001311 patent/WO2001055309A2/en active Search and Examination
- 2001-01-17 CA CA002395849A patent/CA2395849A1/en active Pending
- 2001-01-17 AU AU2001241415A patent/AU2001241415A1/en not_active Abandoned
- 2001-01-17 WO PCT/US2001/001337 patent/WO2001055205A1/en active Search and Examination
- 2001-01-17 CA CA002395872A patent/CA2395872A1/en not_active Withdrawn
- 2001-01-17 AU AU2001241407A patent/AU2001241407A1/en not_active Abandoned
- 2001-01-17 WO PCT/US2001/001310 patent/WO2001055387A1/en active Search and Examination
- 2001-01-17 CA CA002395885A patent/CA2395885A1/en not_active Withdrawn
- 2001-01-17 CA CA002395816A patent/CA2395816A1/en not_active Withdrawn
- 2001-01-17 AU AU2001241417A patent/AU2001241417A1/en not_active Abandoned
- 2001-01-17 CA CA002395787A patent/CA2395787A1/en not_active Withdrawn
- 2001-01-17 WO PCT/US2001/001317 patent/WO2001055201A1/en active Search and Examination
- 2001-01-17 WO PCT/US2001/001325 patent/WO2001055202A1/en active Search and Examination
- 2001-01-17 WO PCT/US2001/001338 patent/WO2001055367A1/en active Search and Examination
- 2001-01-17 CA CA002395729A patent/CA2395729A1/en active Pending
- 2001-01-17 WO PCT/US2001/001354 patent/WO2001057182A2/en not_active Application Discontinuation
- 2001-01-17 WO PCT/US2001/001240 patent/WO2001055302A2/en not_active Application Discontinuation
- 2001-01-17 CA CA002393912A patent/CA2393912A1/en not_active Withdrawn
- 2001-01-17 WO PCT/US2001/001348 patent/WO2001055368A1/en active Search and Examination
- 2001-01-17 CA CA002392757A patent/CA2392757A1/en not_active Abandoned
- 2001-01-17 AU AU2001241406A patent/AU2001241406A1/en not_active Abandoned
- 2001-01-17 CA CA002394841A patent/CA2394841A1/en not_active Withdrawn
- 2001-01-17 CA CA002395738A patent/CA2395738A1/en not_active Withdrawn
- 2001-01-17 CA CA002395654A patent/CA2395654A1/en not_active Withdrawn
- 2001-01-17 WO PCT/US2001/001358 patent/WO2001055163A1/en not_active Application Discontinuation
- 2001-01-17 CA CA002392438A patent/CA2392438A1/en not_active Abandoned
- 2001-01-17 CA CA002392751A patent/CA2392751A1/en not_active Abandoned
- 2001-01-17 CA CA002395666A patent/CA2395666A1/en not_active Withdrawn
- 2001-01-17 CA CA002393002A patent/CA2393002A1/en not_active Withdrawn
- 2001-01-17 CA CA002395178A patent/CA2395178A1/en not_active Withdrawn
- 2001-01-17 WO PCT/US2001/001309 patent/WO2001055308A2/en active Search and Examination
- 2001-01-17 WO PCT/US2001/001312 patent/WO2001054733A1/en active Search and Examination
- 2001-01-17 WO PCT/US2001/001301 patent/WO2001055303A2/en not_active Application Discontinuation
- 2001-01-17 WO PCT/US2001/001353 patent/WO2001055206A1/en not_active Application Discontinuation
- 2001-01-17 WO PCT/US2001/001340 patent/WO2001055321A2/en active Search and Examination
- 2001-01-17 AU AU2001241416A patent/AU2001241416A1/en not_active Abandoned
- 2001-01-17 CA CA002392450A patent/CA2392450A1/en not_active Abandoned
- 2001-01-17 WO PCT/US2001/001359 patent/WO2001055328A2/en active Application Filing
- 2001-01-17 WO PCT/US2001/001314 patent/WO2001055310A2/en active Search and Examination
- 2001-01-17 WO PCT/US2001/001324 patent/WO2001055314A2/en active Search and Examination
- 2001-01-17 WO PCT/US2001/001351 patent/WO2001055355A1/en active Search and Examination
- 2001-01-17 CA CA002395295A patent/CA2395295A1/en not_active Withdrawn
- 2001-01-17 WO PCT/US2001/001322 patent/WO2001055343A1/en active Search and Examination
- 2001-01-17 WO PCT/US2001/001326 patent/WO2001055315A2/en active Search and Examination
- 2001-01-17 WO PCT/US2001/001344 patent/WO2001055324A2/en active Search and Examination
- 2001-01-17 WO PCT/US2001/001333 patent/WO2001055448A1/en active Search and Examination
- 2001-01-17 WO PCT/US2001/001332 patent/WO2001055318A2/en active Search and Examination
- 2001-01-17 CA CA002393618A patent/CA2393618A1/en not_active Abandoned
- 2001-01-17 WO PCT/US2001/001343 patent/WO2001055323A2/en active Search and Examination
- 2001-01-17 CA CA002398411A patent/CA2398411A1/en not_active Withdrawn
- 2001-01-17 AU AU2001241405A patent/AU2001241405A1/en not_active Abandoned
- 2001-01-17 WO PCT/US2001/001306 patent/WO2001055307A2/en active Search and Examination
- 2001-01-17 AU AU2001241408A patent/AU2001241408A1/en not_active Abandoned
- 2001-01-17 WO PCT/US2001/001349 patent/WO2001054474A2/en active Search and Examination
- 2001-01-17 WO PCT/US2001/001302 patent/WO2001055304A2/en active Search and Examination
- 2001-01-17 WO PCT/US2001/001336 patent/WO2001055204A1/en active Search and Examination
- 2001-01-17 CA CA002395724A patent/CA2395724A1/en active Pending
- 2001-01-17 CA CA002397407A patent/CA2397407A1/en not_active Withdrawn
- 2001-01-17 WO PCT/US2001/001327 patent/WO2001055203A1/en active Search and Examination
- 2001-01-17 CA CA002395671A patent/CA2395671A1/en not_active Withdrawn
- 2001-01-17 WO PCT/US2001/001313 patent/WO2001055200A1/en active Search and Examination
- 2001-01-17 WO PCT/US2001/001316 patent/WO2001054473A2/en active Search and Examination
- 2001-01-17 AU AU2001241412A patent/AU2001241412A1/en not_active Abandoned
- 2001-01-17 WO PCT/US2001/001352 patent/WO2001055327A2/en not_active Application Discontinuation
- 2001-01-17 WO PCT/US2001/001345 patent/WO2001055325A2/en active Search and Examination
- 2001-01-17 AU AU2001241414A patent/AU2001241414A1/en not_active Abandoned
- 2001-01-17 CA CA002395858A patent/CA2395858A1/en not_active Withdrawn
- 2001-01-17 WO PCT/US2001/001350 patent/WO2001055350A1/en active Search and Examination
- 2001-01-17 CA CA002395734A patent/CA2395734A1/en not_active Withdrawn
- 2001-01-17 WO PCT/US2001/001321 patent/WO2001055312A2/en active Search and Examination
- 2001-01-17 CA CA002392428A patent/CA2392428A1/en not_active Abandoned
- 2001-01-17 CA CA002392422A patent/CA2392422A1/en not_active Abandoned
- 2001-01-17 WO PCT/US2001/001341 patent/WO2001055322A2/en active Search and Examination
- 2001-01-17 AU AU2001241418A patent/AU2001241418A1/en not_active Abandoned
- 2001-01-17 WO PCT/US2001/001357 patent/WO2001055208A1/en not_active Application Discontinuation
- 2001-01-17 CA CA002394039A patent/CA2394039A1/en not_active Abandoned
- 2001-01-17 AU AU2001241413A patent/AU2001241413A1/en not_active Abandoned
- 2001-01-17 CA CA002395693A patent/CA2395693A1/en active Pending
- 2001-01-17 AU AU2001241409A patent/AU2001241409A1/en not_active Abandoned
- 2001-01-17 WO PCT/US2001/001328 patent/WO2001055316A2/en active Search and Examination
- 2001-01-17 CA CA002395403A patent/CA2395403A1/en not_active Withdrawn
- 2001-01-17 WO PCT/US2001/001239 patent/WO2001055301A2/en active Search and Examination
- 2001-01-17 WO PCT/US2001/001330 patent/WO2001055447A1/en active Search and Examination
- 2001-01-17 CA CA002392398A patent/CA2392398A1/en not_active Abandoned
- 2001-01-17 CA CA002397839A patent/CA2397839A1/en not_active Withdrawn
- 2001-01-17 AU AU2001250770A patent/AU2001250770A1/en not_active Abandoned
- 2001-01-17 AU AU2001241410A patent/AU2001241410A1/en not_active Abandoned
- 2001-01-17 WO PCT/US2001/001308 patent/WO2001055364A2/en active Search and Examination
- 2001-01-17 CA CA002395398A patent/CA2395398A1/en not_active Withdrawn
- 2001-01-17 WO PCT/US2001/001335 patent/WO2001055319A2/en active Search and Examination
- 2001-01-17 WO PCT/US2001/001339 patent/WO2001055320A2/en not_active Application Discontinuation
- 2001-01-17 CA CA002395699A patent/CA2395699A1/en active Pending
- 2001-01-17 WO PCT/US2001/001355 patent/WO2001055207A1/en not_active Application Discontinuation
- 2001-01-17 CA CA002398877A patent/CA2398877A1/en not_active Withdrawn
- 2001-02-05 AU AU4313701A patent/AU4313701A/en active Pending
- 2001-02-08 AU AU4141101A patent/AU4141101A/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2001055350A8 (en) | Nucleic acids, proteins, and antibodies | |
| WO2002000677A8 (en) | Nucleic acids, proteins, and antibodies | |
| WO2001059063A3 (en) | Nucleic acids, proteins, and antibodies | |
| WO2001055317A3 (en) | Nucleic acids, proteins, and antibodies | |
| WO2001055300A3 (en) | Nucleic acids, proteins, and antibodies | |
| WO2001055313A3 (en) | Nucleic acids, proteins, and antibodies | |
| WO2001055167A8 (en) | Nucleic acids, proteins, and antibodies | |
| WO2001055329A3 (en) | Nucleic acids, proteins, and antibodies | |
| WO2001055162A8 (en) | Nucleic acids, proteins, and antibodies |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
| AK | Designated states |
Kind code of ref document: C1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
| AL | Designated countries for regional patents |
Kind code of ref document: C1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
| CFP | Corrected version of a pamphlet front page | ||
| CR1 | Correction of entry in section i |
Free format text: PAT. BUL. 31/2001 UNDER "PUBLISHED", ADD "WITH SEQUENCE LISTING PART OF DESCRIPTION PUBLISHED SEPARATELY IN ELECTRONIC FORM AND AVAILABLE UPON REQUEST FROM THE INTERNATIONAL BUREAU." |
|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
| WWE | Wipo information: entry into national phase |
Ref document number: 2392422 Country of ref document: CA |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 2001914330 Country of ref document: EP |
|
| WWP | Wipo information: published in national office |
Ref document number: 2001914330 Country of ref document: EP |
|
| WWW | Wipo information: withdrawn in national office |
Ref document number: 2001914330 Country of ref document: EP |
|
| REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
| NENP | Non-entry into the national phase |
Ref country code: JP |
|
| DPE2 | Request for preliminary examination filed before expiration of 19th month from priority date (pct application filed from 20040101) |